Arkolith/Insider Trading/ATRA/Form 4

Henrich Jill

EVP, Global Head RA & QualityAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed May 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2024Sell(S)26K$0.62$16K529K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-001557) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML